Published : Apr-2018
No. of Pages : 41
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Osteoporosis: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global and Historical Trends 10
3.4 Forecast Methodology 11
3.4.1 Sources 11
3.4.2 Forecast Assumptions and Methods 15
3.5 Epidemiological Forecast for Osteoporosis (2017-2027) 22
3.5.1 Total Prevalent Cases of Osteoporosis 22
3.5.2 Age-Specific Total Prevalent Cases of Osteoporosis 24
3.5.3 Sex-Specific Total Prevalent Cases of Osteoporosis 25
3.5.4 Total Prevalent Cases of Osteoporosis by Primary and Secondary Osteoporosis 25
3.5.5 Total Prevalent Cases of Primary Osteoporosis by Type 26
3.5.6 Total Prevalent Cases of Osteoporosis Secondary to Glucocorticoid Use 27
3.5.7 Diagnosed Prevalent Cases of Osteoporosis 28
3.5.8 Age-Specific Diagnosed Prevalent Cases of Osteoporosis 29
3.5.9 Sex-Specific Diagnosed Prevalent Cases of Osteoporosis 30
3.5.10 Diagnosed Prevalent Cases of Osteoporosis by Primary and Secondary Osteoporosis 30
3.5.11 Diagnosed Prevalent Cases of Primary Osteoporosis by Type 31
3.5.12 Diagnosed Prevalent Cases of Osteoporosis Secondary to Glucocorticoid Use 32
3.5.13 Total Prevalent Cases and Diagnosed Prevalent Cases of Osteopenia 33
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 34
4 Appendix 35
4.1 Bibliography 35
4.2 High-Prescribing Physician Survey 38
4.3 About the Authors 39
4.3.1 Epidemiologist 39
4.3.2 Reviewers 39
4.3.3 Global Director of Therapy Analysis and Epidemiology 40
4.3.4 Global Head and EVP of Healthcare Operations and Strategy 40
4.4 About GlobalData 41
4.5 Contact Us 41
4.6 Disclaimer 41
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Osteoporosis 9
Table 2: 7MM Total Prevalent Cases of Osteoporosis by Primary Osteoporosis and Secondary Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 26
Table 3: 7MM, Total Prevalent Cases of Primary Osteoporosis by Type, Ages ?30 Years, N, 2017 26
Table 4: 7MM Diagnosed Prevalent Cases of Osteoporosis by Primary Osteoporosis and Secondary Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 31
Table 5: 7MM, Diagnosed Prevalent Cases of Primary Osteoporosis by Type, Ages ?30 Years, N, 2017 31
Table 6: 7MM Total Prevalent Cases and Diagnosed Prevalent Cases of Osteopenia, Both Sexes, Ages ?30 Years, N, 2017 33
Table 7: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2017 38
1.2 List of Figures
Figure 1: 7MM, Total Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, 2017 and 2027 5
Figure 2: 7MM, Diagnosed Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, 2017 and 2027 6
Figure 3: 7MM, Age-Standardized Total Prevalence of Osteoporosis, Men and Women, Ages ?30 Years, 2017 10
Figure 4: 7MM, Age-Standardized Diagnosed Prevalence of Osteoporosis, Men and Women, Ages ?30 Years, 2017 11
Figure 5: 7MM, Sources Used and Not Used to Forecast Total Prevalent Cases of Osteoporosis 12
Figure 6: 7MM, Sources Used to Forecast Total Prevalent Cases and Diagnosed Prevalent Cases of Primary and Secondary 13
Figure 7: 7MM, Sources Used to Forecast Total Prevalent Cases of Osteopenia 13
Figure 8: 7MM, Sources Used to Forecast Diagnosed Prevalent Cases of Osteoporosis 14
Figure 9: 7MM, Sources Used to Forecast Diagnosed Prevalent Cases of Osteopenia 14
Figure 10: 7MM, Total Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 23
Figure 11: 7MM, Age-Specific Total Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 24
Figure 12: 7MM, Sex-Specific Total Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 25
Figure 13: 7MM, Total Prevalent Cases of Osteoporosis Secondary to Glucocorticoid Use, Both Sexes, Ages ?30 Years, N, 2017 27
Figure 14: 7MM, Diagnosed Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 28
Figure 15: 7MM, Age-Specific Diagnosed Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 29
Figure 16: 7MM, Sex-Specific Diagnosed Prevalent Cases of Osteoporosis, Both Sexes, Ages ?30 Years, N, 2017 30
Figure 17: 7MM, Diagnosed Prevalent Cases of Osteoporosis Secondary to Glucocorticoid Use, Both Sexes, Ages ?30 Years, N, 2017 32
